Stewart, Douglas R.
Korf, Bruce R.
Nathanson, Katherine L.
Stevenson, David A.
Yohay, Kaleb
Article History
Received: 4 September 2018
Accepted: 6 September 2018
First Online: 4 October 2018
Disclosure
: D.A.S. has been a consultant for and received compensation from Lineagen, Alexion, and GLG. B.R.K. has been a consultant for Novartis and received a travel grant from AstraZeneca. The other authors declare no conflicts of interest.